首页> 外文期刊>中国癌症研究(英文版) >Cross-Talk between Extracellular S1P/S1P2 and P42/44 MAPK in bcr/abl Positive Chronic Myeloid Leukemia Cells
【24h】

Cross-Talk between Extracellular S1P/S1P2 and P42/44 MAPK in bcr/abl Positive Chronic Myeloid Leukemia Cells

机译:bcr / abl阳性慢性粒细胞白血病细胞中细胞外S1P / S1P2与P42 / 44 MAPK的交叉对话

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: BCR/ABL oncoprotein-expression is associated with uncontrolled cell growth. Sphingosine kinase 1 (SPK1) regulates the production of sphingosine 1-phosphate (S1P), a key lipid signal molecular in cell proliferation and survival. The objective of this study was to elucidate the roles of S1P and its receptors in bcr/abl positive chronic myeloid leukemia (CML) cells.Methods: The expressions of S1P receptors: S1P1, S1P2 and S1P3 in CML cells were detected by RT-PCR. SPK1 expression, activity and extracellular S1P were determined in ECV304 and HL-60 cells which were transfected with bcr/abl gene. To elucidate the relationship between the BCR/ABL, ERK/MAPK (extracellular signal-regulated kinase/mitogen-activated protein kinase), SPK/S1P and S1P/S1P2 signal pathways, bcr/abl positive CML cell line K562 was treated with STI571, PD98059, N,N-dimethyl sphingosine (DMS) and JTE-013.Results: Retrovirus-mediated overexpression of bcr/abl gene in ECV304 and HL-60 cells resulted in upregulation of the expression, activity of SPK1 and increase of the secretion of S1P, whereas treatment of STI571 and PD98059 decreased the BCR/ABL-induced S1P secretion. Treatment of DMS reduced S1P secretion and P42/44MAPK phosphorylation. S1P2-selective antagonist JTE-013 could also decrease P42/44MAPK phosphorylation. Conclusion: These results suggest that BCR/ABL up-regulates extracellular sphingosine 1-phosphate through sphingosine kinase 1 and there is cross-talk between SPK1/S1P/S1P2 and P42/44MAPK in bcr/abl positive CML cells.
机译:目的:BCR / ABL癌蛋白表达与细胞生长不受控制有关。鞘氨醇激酶1(SPK1)调节鞘氨醇1-磷酸(S1P)的产生,鞘氨醇1-磷酸(S1P)是细胞增殖和存活中的关键脂质信号分子。本研究的目的是阐明S1P及其受体在bcr / abl阳性慢性粒细胞白血病(CML)细胞中的作用。方法:通过RT-PCR检测S1P受体S1P1,S1P2和S1P3在CML细胞中的表达。 。在用bcr / abl基因转染的ECV304和HL-60细胞中测定SPK1的表达,活性和细胞外S1P。为了阐明BCR / ABL,ERK / MAPK(细胞外信号调节激酶/促分裂原活化蛋白激酶),SPK / S1P和S1P / S1P2信号通路之间的关系,用STI571处理了bcr / abl阳性CML细胞系K562,结果:逆转录病毒介导的ECV304和HL-60细胞中bcr / abl基因的过表达导致SPK1的表达,SPK1的活性上调和分泌增加,从而导致PD98059,N,N-二甲基鞘氨醇(DMS)和JTE-013。 S1P,而STI571和PD98059的治疗降低了BCR / ABL诱导的S1P分泌。 DMS的治疗可减少S1P分泌和P42 / 44MAPK磷酸化。 S1P2选择性拮抗剂JTE-013也可以降低P42 / 44MAPK磷酸化。结论:这些结果表明,BCR / ABL通过鞘氨醇激酶1上调细胞外鞘氨醇1-磷酸,并且在bcr / abl阳性CML细胞中SPK1 / S1P / S1P2与P42 / 44MAPK之间存在串扰。

著录项

  • 来源
    《中国癌症研究(英文版)》 |2009年第1期|20-27|共8页
  • 作者单位

    Deparment of Biochemistry and Molecular Biology, Anhui Medical University, Hefei 230032, China;

    Key Laboratory of Carcinogenesis and Translational Research Ministry of Education, Department of Interventional Therapy, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing 100142, China;

    Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China;

    Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China;

    Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China;

    Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China;

    Department of Experimental Hematology, Beijing Institute of Radiation Medicine, Beijing 100850, China;

    Deparment of Biochemistry and Molecular Biology, Anhui Medical University, Hefei 230032, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 慢性白血病;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号